Ruling Puts Drug Cos. In Prime Position To Avert State Court

Law360, New York (November 14, 2012, 9:53 PM EST) -- A New York federal judge ruled Friday that state-law claims targeting three generic-drug manufacturers involve federal questions consequential enough to prevent their removal to state court, a decision that should help other generics makers keep cases in the friendlier confines of federal court.

U.S. District Judge William Kuntz denied a remand motion filed by a group of plaintiffs claiming they suffered tissue damage from taking generic anti-seizure drugs manufactured by Sun Pharmaceutical Industries Inc., Taro Pharmaceuticals USA Inc. and Caraco Pharmaceutical Laboratories Ltd. The judge also...
To view the full article, register now.